Literature DB >> 1623581

Antibody multispecificity in immunoassay interference.

S S Levinson1.   

Abstract

Recent findings indicate that many endogenous antibodies exhibit multispecificity. These antibodies exhibit a potential for interference with immunoassays. Antibodies that interfere with immunoassays have been called heterophile or heterophilic antibodies. The purpose of this review is: (1) to identify the nature of heterophile antibodies; (2) to delineate the processes that produce them; (3) to examine the mechanisms by which these antibodies cause interference; and (4) to explore how this information can be used to reduce immunoassay interference. In addition to producing specific antibodies, the process of antibody production gives rise to rudimentary antibodies that are polyspecific; e.g., the antigen-combining site has an affinity for antigens of different chemical composition. This process also generates idiotypic antibodies containing cross-reactive idiotopes. These antibodies along with rheumatoid factors, which are themselves polyspecific and rich in cross-reactive idiotopes, are inherent parts of the process of antibody production, and exhibit multispecificity. Mechanisms by which these antibodies cause immunoassay interference are outlined. These properties of antibodies may have substantial consequence in directing future assays toward greater clinical predictive value.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1623581     DOI: 10.1016/0009-9120(92)80048-l

Source DB:  PubMed          Journal:  Clin Biochem        ISSN: 0009-9120            Impact factor:   3.281


  11 in total

1.  Heterophile antibodies to bovine and caprine proteins causing false-positive human immunodeficiency virus type 1 and other enzyme-linked immunosorbent assay results.

Authors:  J H Willman; T B Martins; T D Jaskowski; H R Hill; C M Litwin
Journal:  Clin Diagn Lab Immunol       Date:  1999-07

2.  Heterophile antibody interference in a multiplexed fluorescent microsphere immunoassay for quantitation of cytokines in human serum.

Authors:  Thomas B Martins; Brian M Pasi; Christine M Litwin; Harry R Hill
Journal:  Clin Diagn Lab Immunol       Date:  2004-03

Review 3.  Ligand binding assays in the 21st century laboratory: recommendations for characterization and supply of critical reagents.

Authors:  Denise M O'Hara; Valerie Theobald; Adrienne Clements Egan; Joel Usansky; Murli Krishna; Julie TerWee; Mauricio Maia; Frank P Spriggs; John Kenney; Afshin Safavi; Jeannine Keefe
Journal:  AAPS J       Date:  2012-03-14       Impact factor: 4.009

4.  Heterophile antibodies segregate in families and are associated with protection from type 1 diabetes.

Authors:  J X She; T M Ellis; S B Wilson; C H Wasserfall; M Marron; S Reimsneider; S C Kent; D A Hafler; D S Neuberg; A Muir; J L Strominger; M A Atkinson
Journal:  Proc Natl Acad Sci U S A       Date:  1999-07-06       Impact factor: 11.205

5.  False serum calcitonin high levels using a non-competitive two-site IRMA.

Authors:  M Tommasi; A Brocchi; A Cappellini; S Raspanti; M Mannelli
Journal:  J Endocrinol Invest       Date:  2001-05       Impact factor: 4.256

6.  Therapeutic drug monitoring during pregnancy and lactation: thyroid function assessment in pregnancy-challenges and solutions.

Authors:  Offie P Soldin
Journal:  Ther Drug Monit       Date:  2010-06       Impact factor: 3.681

7.  Raised tryptase without anaphylaxis or mastocytosis: heterophilic antibody interference in the serum tryptase assay.

Authors:  R Sargur; D Cowley; S Murng; G Wild; K Green; A Shrimpton; W Egner
Journal:  Clin Exp Immunol       Date:  2011-03       Impact factor: 4.330

Review 8.  Hypothyroxinemia and pregnancy.

Authors:  Roberto Negro; Offie P Soldin; Maria-Jesus Obregon; Alex Stagnaro-Green
Journal:  Endocr Pract       Date:  2011 May-Jun       Impact factor: 3.443

9.  Assay interference leading to misdiagnosis of central precocious puberty.

Authors:  David G Segal; Linda A DiMeglio; Kenneth W Ryder; Pamela A Vollmer; Ora Hirsch Pescovitz
Journal:  Endocrine       Date:  2003-04       Impact factor: 3.633

10.  The gut-joint axis: cross reactive food antibodies in rheumatoid arthritis.

Authors:  M Hvatum; L Kanerud; R Hällgren; P Brandtzaeg
Journal:  Gut       Date:  2006-02-16       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.